New drug cocktail offers hope for patients out of options
NCT ID NCT02718833
Summary
This study is testing whether combining four already-approved drugs works better together for people with multiple myeloma that has returned or stopped responding to other treatments. It will involve about 52 adults whose cancer has progressed despite previous therapies. The main goals are to see how well the combination shrinks the cancer and what side effects patients experience.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Mass General/North Shore Cancer Center
Danvers, Massachusetts, 01923, United States
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
-
Newton-Wellesley Hospital
Newton, Massachusetts, 02462, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of Rochester
Rochester, New York, 14642, United States
Conditions
Explore the condition pages connected to this study.